Our data also indicate that the upregulation of BDNF and p-CREB by ARBs may contribute to their neuroprotective effects in diabetic individuals and could be selectively targeted to alleviate some of the depressive symptoms associated with diabetes. Here, BDNF is linked to diabetes mellitus.